+100%-
+100%-
 Ampligen is a breakthrough for some people with ME/CFS - yet it is still not available.

Ampligen is a breakthrough for some people with ME/CFS – yet it is still not available.

With a UK trial for Rituximab at least temporarily in doubt, let’s turn the focus to Ampligen – a drug that is potentially one trial away from being approved for ME/CFS.  Ampligen is still the only drug that’s been able to move the needle on exercise in ME/CFS.

With NIH director Collins making noises about a possible Ampligen trial and a new review paper out, it’s time to make the case for Ampligen.

Check out a Simmaron Research Foundation sponsored blog:

GET FREE ME/CFS AND FIBROMYALGIA INFO

Like the blog you're reading? Don't miss another one.

Get the most in-depth information available on the latest ME/CFS and FM treatment and research findings by registering for Health Rising's free  ME/CFS and Fibromyalgia blog here.

Pin It on Pinterest

Shares
Share This